At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 4 Randomized Double-Blind Double-Dummy Placebo & Active-Controlled Single-Dose Six-Way Crossover Study Evaluating the Abuse Potential of Lyrica® Taken Orally With Oxycodone HCL in Healthy Non-Drug Dependent Recreational Opioid Users
In Brief
A Phase 4 clinical trial evaluating Pregabalin 300mg, pregabalin 450 mg, and 4 other interventions for Abuse Potential. Completed, enrolled 60 participants across 1 site.
Detailed Summary
This is a Phase 4 clinical study in healthy non-drug dependent recreational opioid users to assess the abuse potential of Lyrica when taken alone or in combination with oxycodone.
Study Details
Timeline
Interventions
Participant will receive an oral dose of pregabalin 300 mg
Participant will receive an oral dose of pregabalin 450 mg
Participant will receive an oral dose of pregabalin 300 mg and oxycodone 20 mg
Participant will receive an oral dose of pregabalin 450 mg and oxycodone 20 mg
Participant will receive an oral dose of oxycodone 20 mg
Participant will receive an oral dose of placebo